Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NUFIP2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | affects expression | ISO | Nufip2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of NUFIP2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NUFIP2 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nufip2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NUFIP2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nufip2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NUFIP2 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Nufip2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | increases expression | ISO | Nufip2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of NUFIP2 mRNA | CTD | PMID:33297965 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NUFIP2 mRNA | CTD | PMID:32763439 | benzo[a]pyrene | multiple interactions | ISO | Nufip2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NUFIP2 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NUFIP2 intron | CTD | PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | benzo[b]fluoranthene | multiple interactions | ISO | Nufip2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NUFIP2 mRNA | CTD | PMID:27858113 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NUFIP2 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of NUFIP2 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NUFIP2 protein | CTD | PMID:37567409 | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of NUFIP2 protein | CTD | PMID:34186270 | cadmium dichloride | decreases expression | ISO | Nufip2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of NUFIP2 mRNA | CTD | PMID:33453195 | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of NUFIP2 protein | CTD | PMID:35688186 | chrysene | multiple interactions | ISO | Nufip2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NUFIP2 mRNA | CTD | PMID:27858113 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NUFIP2 mRNA | CTD | PMID:27594783 | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of NUFIP2 protein | CTD | PMID:35688186 | cyclosporin A | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of NUFIP2 mRNA | CTD | PMID:19770486 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUFIP2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NUFIP2 mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUFIP2 protein | CTD | PMID:23301498 | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of NUFIP2 mRNA | CTD | PMID:23649840 | folic acid | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of NUFIP2 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of NUFIP2 mRNA | CTD | PMID:20655997 | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of NUFIP2 protein | CTD | PMID:37730182 | indometacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of NUFIP2 mRNA | CTD | PMID:16984733 | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUFIP2 mRNA | CTD | PMID:29432896 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of NUFIP2 protein | CTD | PMID:32959892 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of NUFIP2 intron | CTD | PMID:30157460 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of NUFIP2 mRNA | CTD | PMID:23649840 | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of NUFIP2 mRNA | CTD | PMID:31629900 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of NUFIP2 mRNA | CTD | PMID:28001369 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of NUFIP2 mRNA | CTD | PMID:28001369 | miconazole | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | Miconazole results in decreased expression of NUFIP2 mRNA | CTD | PMID:27462272 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NUFIP2 mRNA | CTD | PMID:22230336 | phenobarbital | affects expression | ISO | Nufip2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of NUFIP2 mRNA | CTD | PMID:23091169 | pirinixic acid | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of NUFIP2 mRNA | CTD | PMID:20813756 and PMID:23811191 | quercetin | decreases phosphorylation | EXP | | 6480464 | Quercetin results in decreased phosphorylation of NUFIP2 protein | CTD | PMID:35688186 | resveratrol | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | resveratrol results in decreased expression of NUFIP2 protein | CTD | PMID:25505154 | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | sodium arsenate | increases expression | ISO | Nufip2 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of NUFIP2 mRNA | CTD | PMID:21795629 | tetrachloromethane | increases expression | ISO | Nufip2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NUFIP2 mRNA | CTD | PMID:27339419 | tetrahydropalmatine | decreases expression | EXP | | 6480464 | tetrahydropalmatine results in decreased expression of NUFIP2 protein | CTD | PMID:20109541 | tetraphene | multiple interactions | ISO | Nufip2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NUFIP2 mRNA | CTD | PMID:27858113 | thioacetamide | increases expression | ISO | Nufip2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of NUFIP2 mRNA | CTD | PMID:34492290 | troglitazone | decreases expression | ISO | Nufip2 (Mus musculus) | 6480464 | troglitazone results in decreased expression of NUFIP2 mRNA | CTD | PMID:28973697 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of NUFIP2 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NUFIP2 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUFIP2 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NUFIP2 mRNA | CTD | PMID:23179753 more ... | vinclozolin | increases expression | ISO | Nufip2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of NUFIP2 mRNA | CTD | PMID:23034163 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NUFIP2 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NUFIP2 mRNA | CTD | PMID:18593933 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Cellular Component
Molecular Function
